BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32694158)

  • 1. Clinical Evaluation of (4S)-4-(3-[
    Park SY; Na SJ; Kumar M; Mosci C; Wardak M; Koglin N; Bullich S; Mueller A; Berndt M; Stephens AW; Cho YM; Ahn H; Chae SY; Kim HO; Moon DH; Gambhir SS; Mittra ES
    Clin Cancer Res; 2020 Oct; 26(20):5380-5387. PubMed ID: 32694158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective comparison of (4S)-4-(3-
    Cheng MF; Huang YY; Ho BY; Kuo TC; Hsin LW; Shiue CY; Kuo HC; Jeng YM; Yen RF; Tien YW
    Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):810-820. PubMed ID: 30635754
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Wardak M; Sonni I; Fan AP; Minamimoto R; Jamali M; Hatami N; Zaharchuk G; Fischbein N; Nagpal S; Li G; Koglin N; Berndt M; Bullich S; Stephens AW; Dinkelborg LM; Abel T; Manning HC; Rosenberg J; Chin FT; Gambhir SS; Mittra ES
    Radiology; 2022 Jun; 303(3):620-631. PubMed ID: 35191738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (4S)-4-(3-18F-fluoropropyl)-L-glutamate for imaging of xC transporter activity in hepatocellular carcinoma using PET: preclinical and exploratory clinical studies.
    Baek S; Mueller A; Lim YS; Lee HC; Lee YJ; Gong G; Kim JS; Ryu JS; Oh SJ; Lee SJ; Bacher-Stier C; Fels L; Koglin N; Schatz CA; Dinkelborg LM; Moon DH
    J Nucl Med; 2013 Jan; 54(1):117-23. PubMed ID: 23232273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploratory clinical trial of (4S)-4-(3-[18F]fluoropropyl)-L-glutamate for imaging xC- transporter using positron emission tomography in patients with non-small cell lung or breast cancer.
    Baek S; Choi CM; Ahn SH; Lee JW; Gong G; Ryu JS; Oh SJ; Bacher-Stier C; Fels L; Koglin N; Hultsch C; Schatz CA; Dinkelborg LM; Mittra ES; Gambhir SS; Moon DH
    Clin Cancer Res; 2012 Oct; 18(19):5427-37. PubMed ID: 22893629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial evaluation of (4S)-4-(3-[
    Park SY; Mosci C; Kumar M; Wardak M; Koglin N; Bullich S; Mueller A; Berndt M; Stephens AW; Chin FT; Gambhir SS; Mittra ES
    EJNMMI Res; 2020 Aug; 10(1):100. PubMed ID: 32857284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies.
    Mittra ES; Koglin N; Mosci C; Kumar M; Hoehne A; Keu KV; Iagaru AH; Mueller A; Berndt M; Bullich S; Friebe M; Schmitt-Willich H; Gekeler V; Fels LM; Bacher-Stier C; Moon DH; Chin FT; Stephens AW; Dinkelborg LM; Gambhir SS
    PLoS One; 2016; 11(2):e0148628. PubMed ID: 26890637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of [
    Kavanaugh G; Williams J; Morris AS; Nickels ML; Walker R; Koglin N; Stephens AW; Washington MK; Geevarghese SK; Liu Q; Ayers D; Shyr Y; Manning HC
    Mol Imaging Biol; 2016 Dec; 18(6):924-934. PubMed ID: 27677886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Evaluation of [
    Colovic M; Yang H; Southcott L; Merkens H; Colpo N; Bénard F; Schaffer P
    J Nucl Med; 2023 Aug; 64(8):1314-1321. PubMed ID: 37116917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotracer stereochemistry affects substrate affinity and kinetics for improved imaging of system x
    Greenwood HE; Edwards R; Koglin N; Berndt M; Baark F; Kim J; Firth G; Khalil E; Mueller A; Witney TH
    Theranostics; 2022; 12(4):1921-1936. PubMed ID: 35198080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [
    Hoehne A; James ML; Alam IS; Ronald JA; Schneider B; D'Souza A; Witney TH; Andrews LE; Cropper HC; Behera D; Gowrishankar G; Ding Z; Wyss-Coray T; Chin FT; Biswal S; Gambhir SS
    J Neuroinflammation; 2018 Feb; 15(1):55. PubMed ID: 29471880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploratory Clinical Investigation of (4S)-4-(3-18F-Fluoropropyl)-L-Glutamate PET of Inflammatory and Infectious Lesions.
    Chae SY; Choi CM; Shim TS; Park Y; Park CS; Lee HS; Lee SJ; Oh SJ; Kim SY; Baek S; Koglin N; Stephens AW; Dinkelborg LM; Moon DH
    J Nucl Med; 2016 Jan; 57(1):67-9. PubMed ID: 26471694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-Body Integrated [
    Guberina N; Hetkamp P; Ruebben H; Fendler W; Grueneisen J; Suntharalingam S; Kirchner J; Puellen L; Harke N; Radtke JP; Umutlu L; Hadaschik BA; Herrmann K; Forsting M; Wetter A
    Mol Imaging Biol; 2020 Jun; 22(3):788-796. PubMed ID: 31482413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [
    Green MA; Hutchins GD; Bahler CD; Tann M; Mathias CJ; Territo W; Sims J; Polson H; Alexoff D; Eckelman WC; Kung HF; Fletcher JW
    Mol Imaging Biol; 2020 Jun; 22(3):752-763. PubMed ID: 31429050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
    Kang JH; Jung DW; Pak KJ; Kim IJ; Kim HJ; Cho JK; Shin SC; Wang SG; Lee BJ
    Head Neck; 2018 Jan; 40(1):94-102. PubMed ID: 29130586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Prostate Cancer Glucose Metabolism Detected by
    Lavallée E; Bergeron M; Buteau FA; Blouin AC; Duchesnay N; Dujardin T; Tiguert R; Lacombe L; Fradet V; Makao-Nguile M; Fradet Y; Beauregard JM; Pouliot F
    Eur Urol Focus; 2019 Nov; 5(6):998-1006. PubMed ID: 29609897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early PET imaging with [68]Ga-PSMA-11 increases the detection rate of local recurrence in prostate cancer patients with biochemical recurrence.
    Uprimny C; Kroiss AS; Fritz J; Decristoforo C; Kendler D; von Guggenberg E; Nilica B; Maffey-Steffan J; di Santo G; Bektic J; Horninger W; Virgolini IJ
    Eur J Nucl Med Mol Imaging; 2017 Sep; 44(10):1647-1655. PubMed ID: 28589253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BAY 1075553 PET-CT for Staging and Restaging Prostate Cancer Patients: Comparison with [18F] Fluorocholine PET-CT (Phase I Study).
    Beheshti M; Kunit T; Haim S; Zakavi R; Schiller C; Stephens A; Dinkelborg L; Langsteger W; Loidl W
    Mol Imaging Biol; 2015 Jun; 17(3):424-33. PubMed ID: 25315836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Physiologic (18)F FSPG Uptake in Healthy Volunteers.
    Mosci C; Kumar M; Smolarz K; Koglin N; Stephens AW; Schwaiger M; Gambhir SS; Mittra ES
    Radiology; 2016 Jun; 279(3):898-905. PubMed ID: 26785040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.